title: Neuropsychiatric manifestations and treatment of disseminated neurocysticercosis: a compilation of three cases.
abstract: BACKGROUND
  Neurocysticercosis (NCC) is the most serious form of cysticercal infection and is a major public health problem in the developing world. NCC presents with a range of psychiatric symptoms besides neurological symptoms. There have been few reports from the Asian continent describing the neuropsychiatric manifestations. Our aim was to report manifestations and treatment issues in three cases with disseminated NCC.
  
  
  RESULTS
  Informed consent was obtained from all the three patients for the purpose of reporting. All three had multiple cysticerci in the brain and presented with several neuropsychiatric manifestations. All the patients had epilepsy and in addition they had varying psychiatric symptoms of delusions, hallucinations and catatonia, and cognitive symptoms. Also, interestingly in one patient, worsening of psychiatric and neurological symptoms correlated with anti-helminthic treatment. The psychotic symptoms responded to anti-psychotic treatment in one case. Anti-epileptics and steroid courses when given improved the clinical status.
  
  
  CONCLUSIONS
  NCC presents with a myriad of manifestations. Epilepsy, psychotic and cognitive symptoms respond to symptomatic treatment. Use of anti-parasitic agents might worsen the symptoms as has been reported in a few cases earlier.
authors.affiliation: Department of Psychiatry, Post-Graduate Institute of Medical Education and Research, Chandigarh 160012, India. drruchitashah@gmail.com
authors.forename: Ruchita
authors.initials: R
authors.lastname: Shah
authors.forename: Subho
authors.initials: S
authors.lastname: Chakrabarti
mesh_terms: D000328:Adult; D000871:Anthelmintics / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D004827:Epilepsy / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006212:Hallucinations / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D020019:Neurocysticercosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D000927:Anticonvulsants; D014150:Antipsychotic Agents